VetRenew Stem Cell Therapy

04/06/2026

✨ Could Stem Cell Therapy Change the Way You Treat Chronic Conditions in Your Pet?

What if managing chronic pain, such as arthritis or inflammatory disease in pets, could go beyond simply controlling symptoms?
Stem Cell Therapy is transforming modern veterinary medicine — helping dogs, cats, and horses with conditions like:
🐾 Osteoarthritis
🐾 Tendon & ligament injuries
🐾 Chronic wounds
🐾 Eye disease
🐾 Inflammatory conditions

Recent veterinary research shows mesenchymal stem cells (MSCs) may help:
✔ Reduce inflammation
✔ Improve mobility and comfort
✔ Support tissue repair
✔ Improve quality of life
✔ Potentially slow disease progression
For many pets struggling with chronic conditions, regenerative medicine is opening exciting new possibilities. 💙
Click below to understand
🔬 How stem cell therapy works
📚 Get the latest evidence-based veterinary research
🐶 Conditions being treated in practice today
💡 Safety, benefits, and long-term considerations
To find out more, click here : https://www.vetrenew.co.za/stem-cell-therapy-in-veterinary-medicine/

26/02/2026

14/11/2025

As biological therapies continue to evolve as valuable tools in the multimodal management of canine osteoarthritis (OA), so too does the debate pertaining to the cost:benefit conundrum. To support clinical decision-making, below is a concise evidence-based summary of Stem Cell Therapy using mesenchymal stem cells (MSC) therapy

Primary action: Regenerative + immunomodulatory
Tissue impact: Can differentiate into chondrocytes; chondroprotective
Best for: Moderate–severe OA, chronic cases, NSAID-intolerant patients
Duration: 6–18 months or longer
Dosing: Single / infrequent
Safety: Good in controlled studies
OA Role: Moderate–severe OA or refractory cases

Key Clinical Evidence in Dogs
MSC Therapy
Improvement in pain and lameness in prospective controlled trials
Harman et al., 2016
Sustained benefit reported up to 6–18+ months
(Kriston-Pál et al., 2020; Olsson et al., 2021)
Immunomodulatory effects demonstrated (reduced synovial inflammatory mediators, systemic immune activity)
(Beerts et al., 2023)
Most benefit seen in **moderate-to-advanced OA**
* Useful when NSAIDs/injectables insufficient or contraindicated
* Single or limited treatment sessions; allogeneic and off-the-shelf use supported
(Luo et al., 2021)

VetRenew supplies Allogenic Stem Cells that undergo rigorous quality controls. For more information or to discuss any case that you are considering using Stem Cell Therapy on, please feel free to reach out to us on [email protected] or [email protected]

08/08/2025

Mesenchymal stem cells (MSCs) are a popular option when it comes to reducing inflammation and promoting healing in horses, as they carry a very low risk of side effects compared to other types of stem cells. While MSCs were originally used mainly for treating joint and muscle problems, they are now being tested for a variety of other health issues in horses, offering promising new treatment options. (https://pubmed.ncbi.nlm.nih.gov/30929778/)

VetRenew supplies allogenic MSC’s for use in horses to registered veterinarians in South Africa
For more information please contact [email protected]